| Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 5178 | 2018 |
| Projections of the cost of cancer care in the United States: 2010–2020 AB Mariotto, K Robin Yabroff, Y Shao, EJ Feuer, ML Brown Journal of the National Cancer Institute 103 (2), 117-128, 2011 | 3134 | 2011 |
| Cancer treatment and survivorship statistics, 2022 KD Miller, L Nogueira, T Devasia, AB Mariotto, KR Yabroff, A Jemal, ... CA: a cancer journal for clinicians 72 (5), 409-436, 2022 | 2100 | 2022 |
| Annual report to the nation on the status of cancer, 1975–2014, featuring survival A Jemal, EM Ward, CJ Johnson, KA Cronin, J Ma, AB Ryerson, A Mariotto, ... JNCI: Journal of the National Cancer Institute 109 (9), djx030, 2017 | 1722 | 2017 |
| The effect of advances in lung-cancer treatment on population mortality N Howlader, G Forjaz, MJ Mooradian, R Meza, CY Kong, KA Cronin, ... New England Journal of Medicine 383 (7), 640-649, 2020 | 1433 | 2020 |
| Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or … BK Edwards, AM Noone, AB Mariotto, EP Simard, FP Boscoe, SJ Henley, ... Cancer 120 (9), 1290-1314, 2014 | 1402 | 2014 |
| SEER cancer statistics review, 1975-2014 N Howlader, AM Noone, M Krapcho, D Miller, K Bishop, CL Kosary, M Yu, ... Bethesda, MD: National Cancer Institute 2018, 2017 | 1302 | 2017 |
| SEER cancer statistics review, 1975-2013, national cancer institute. bethesda, MD N Howlader, AM Noone, M Krapcho, D Miller, K Bishop, SF Altekruse, ... | 1233* | 2016 |
| Anticipating the “Silver Tsunami”: prevalence trajectories and co-morbidity burden among older cancer survivors in the United States SM Bluethmann, AB Mariotto, JH Rowland Cancer Epidemiology, Biomarkers & Prevention 25 (7), 1029-1036, 2016 | 1088 | 2016 |
| SEER cancer statistics review, 1975–2017 N Howlader, AM Noone, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... National Cancer Institute 4, 2020 | 1085 | 2020 |
| Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context G Draisma, R Etzioni, A Tsodikov, A Mariotto, E Wever, R Gulati, E Feuer, ... Journal of the National Cancer Institute 101 (6), 374-383, 2009 | 1027 | 2009 |
| Cost of care for elderly cancer patients in the United States KR Yabroff, EB Lamont, A Mariotto, JL Warren, M Topor, A Meekins, ... Journal of the National Cancer Institute 100 (9), 630-641, 2008 | 800 | 2008 |
| Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care JS De Moor, AB Mariotto, C Parry, CM Alfano, L Padgett, EE Kent, ... Cancer Epidemiology, Biomarkers & Prevention 22 (4), 561-570, 2013 | 770 | 2013 |
| Economic burden of cancer in the United States: estimates, projections, and future research KR Yabroff, J Lund, D Kepka, A Mariotto Cancer epidemiology, biomarkers & prevention 20 (10), 2006-2014, 2011 | 654 | 2011 |
| Survivors of childhood cancer in the United States: prevalence and burden of morbidity SM Phillips, LS Padgett, WM Leisenring, KK Stratton, K Bishop, KR Krull, ... Cancer Epidemiology, Biomarkers & Prevention 24 (4), 653-663, 2015 | 622 | 2015 |
| Adverse events after outpatient colonoscopy in the Medicare population JL Warren, CN Klabunde, AB Mariotto, A Meekins, M Topor, ML Brown, ... Annals of internal medicine 150 (12), 849-857, 2009 | 573 | 2009 |
| Medical care costs associated with cancer survivorship in the United States AB Mariotto, L Enewold, J Zhao, CA Zeruto, KR Yabroff Cancer epidemiology, biomarkers & prevention 29 (7), 1304-1312, 2020 | 559 | 2020 |
| Estimation of the number of women living with metastatic breast cancer in the United States AB Mariotto, R Etzioni, M Hurlbert, L Penberthy, M Mayer Cancer Epidemiology, Biomarkers & Prevention 26 (6), 809-815, 2017 | 555 | 2017 |
| Quantifying the role of PSA screening in the US prostate cancer mortality decline R Etzioni, A Tsodikov, A Mariotto, A Szabo, S Falcon, J Wegelin, ... Cancer Causes & Control 19, 175-181, 2008 | 536 | 2008 |
| Improved estimates of cancer-specific survival rates from population-based data N Howlader, LAG Ries, AB Mariotto, ME Reichman, J Ruhl, KA Cronin JNCI: Journal of the National Cancer Institute 102 (20), 1584-1598, 2010 | 513 | 2010 |
